Skip to main content

Peer Review reports

From: RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis

Original Submission
20 Jun 2017 Submitted Original manuscript
2 Aug 2017 Reviewed Reviewer Report - Ian Davis
12 Sep 2017 Reviewed Reviewer Report - Kevin Courtney
26 Oct 2017 Author responded Author comments - Lin Yang
Resubmission - Version 2
26 Oct 2017 Submitted Manuscript version 2
29 Nov 2017 Reviewed Reviewer Report - Ian Davis
11 Dec 2017 Reviewed Reviewer Report - Kevin Courtney
18 Dec 2017 Author responded Author comments - Lin Yang
Resubmission - Version 3
18 Dec 2017 Submitted Manuscript version 3
Publishing
5 Feb 2018 Editorially accepted
17 Feb 2018 Article published 10.1186/s12885-018-4091-5

You can find further information about peer review here.

Back to article page